AB SCIENCE
AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. They are innovators and scientific entrepreneurs in the field of life science.
AB SCIENCE
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2001-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.ab-science.com
Total Employee:
101+
Status:
Active
Contact:
+330147200014
Email Addresses:
[email protected]
Total Funding:
27.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.ab-science.com Semrush global rank: 7.3 M Semrush visits lastest month: 532
Unable to get host informations!!!
More informations about "AB Science"
AB Science late-clinical-stage French company founded in 2001
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing innovative drugs for high unmet medical needs. The Company is based …See details»
Governance - AB Science
AB SCIENCE HEADQUARTER. 3, Avenue George V – 75008 PARIS – FRANCE Tel. : +33 (0)1 47 20 00 14 Fax. : +33 (0)1 47 20 24 11. GENERAL INQUIRIES. [email protected]. …See details»
Company – AB Science
AB SCIENCE HEADQUARTER. 3, Avenue George V – 75008 PARIS – FRANCE Tel. : +33 (0)1 47 20 00 14. GENERAL INQUIRIES. [email protected]See details»
AB Science - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +330147200014 AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in …See details»
AB Science - LinkedIn
AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs …See details»
AB Science | Devex
Learn more about AB Science's jobs, projects, latest news, contact information and geographical presence. AB Science is a late-clinical-stage French company founded in 2001 by a team of …See details»
AB Science S.A. (EPA: AB) Company Profile & Overview - Stock …
Jan 3, 2025 AB Science Company Description AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for …See details»
AB Science | European Clinical Trials Information Network
AB Science has undergone several mergers and acquisitions over the years, including the acquisition of the biotechnology company, Novagali Pharma, in 2011. The company has also …See details»
AB Science Company Profile 2025: Stock Performance & Earnings
AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies …See details»
AB Science Company Profile | Management and Employees List
AB Science Profile and History. Founded in 2001, AB Science is a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors …See details»
AB Science - Craft
Oct 29, 2024 AB Science is a pharmaceutical company that engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and …See details»
Corporate Health & Wellness Software - AB Science
AB Science™ is pioneering, innovating, and is established as the thought leader in the area of modifying the health and wellness of your stakeholders and key people. We aid your …See details»
AB Science - Contacts, Employees, Board Members, Advisors
Organization. AB Science . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Contacts 33. ... AB …See details»
AB Science is developing two main compounds
10/10/2024 – AB Science today reports its revenues for the first half of 2024 and provides an update on its activities. Read more. AB SCIENCE HEADQUARTER. 3, Avenue George V – …See details»
AB Science today reports its revenues for the first half of
Sep 29, 2023 AB Science announced on 21 April 2023 the negotiation of a framework agreement under which the terms and conditions of the bond issue agreement (entered into …See details»
AB Science S.A. (LON: 0Q77) Company Profile & Overview - Stock …
Jan 2, 2025 AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies …See details»
AB Science Announces Changes in the Board of Directors
Apr 29, 2022 Board of Directors AB Science has announced the reorganization of its Board of Directors with the co-optation of four new independent directors, Cécile de Guillebon, …See details»
AB Science S.A. (ABSCF) - Yahoo Finance Canada
AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and …See details»
About AB Science – AB Science
AB Science is a clinical-stage pharmaceutical company developing innovative drugs targeting diseases with unmet medical needs. Our two main compounds are developed in the field of …See details»
Corporate Presentation - AB Science
Dubreuil 2009, PLoSONE.4(9):e7258; AB Science. Davis 2011, Nat Biotechnol; 29(11):1046 Masitinib targets mast cells • Masitinib is a potent and selective inhibitor of c-Kit, Lyn, and Fyn …See details»